Related Experiment Video
Updated: Aug 21, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
[Minimal change nephrotic syndrome]
Susumu Uda1, Takahiro Nakayama, Makoto Hirose
1Department of Nephrology, Toshiba Rinkan Hospital.
Abstract:
In minimal change nephrotic syndrome (MCNS), selective proteinuria is associated with structural alterations of the glomerular epithelial cells, such as effacement of the foot process. Although the pathogenesis of MCNS has not been completely clarified, clinical and experimental observations suggest that it results from T cell dysfunction in the pathogenesis. Recently, it has been proposed that the occurrence of MCNS has been associated with type 2 Th (Th2) lymphocyte-dependent conditions and some vascular permeability factors, which are induced by T cell disorder. In general, MCNS has the good long-term outcome with sustained remission and preserved renal function, because almost cases are responsible for the treatment. However, some patients show frequent relapses or resistance to this treatment and need large doses of immunosuppressive agents for a long time. Therefore, we should be care for the complications associated with prolonged these therapies.
Insights
Minimal change nephrotic syndrome (MCNS) involves T cell dysfunction and foot process effacement. While often responsive to treatment, some patients experience relapses or resistance, necessitating careful management of long-term immunosuppressive therapy complications.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Context:
- Minimal change nephrotic syndrome (MCNS) is characterized by selective proteinuria and glomerular epithelial cell foot process effacement.
- The precise pathogenesis of MCNS remains incompletely understood, but T cell dysfunction is implicated.
- Recent research suggests a link between MCNS, T helper 2 (Th2) lymphocyte-dependent conditions, and T cell-induced vascular permeability factors.
Purpose:
- To summarize the current understanding of MCNS pathogenesis, focusing on the role of T cell dysfunction.
- To highlight the clinical course and treatment responses in MCNS patients.
- To emphasize the potential complications associated with prolonged immunosuppressive therapies in MCNS.
Summary:
- MCNS is associated with structural changes in glomerular epithelial cells, specifically foot process effacement.
- Evidence points towards T cell dysfunction, potentially involving Th2 lymphocytes and vascular permeability factors, as a key factor in MCNS development.
- While many MCNS cases achieve remission and maintain renal function with treatment, a subset exhibits frequent relapses or treatment resistance.
Impact:
- Understanding the role of T cell dysfunction in MCNS can guide the development of targeted therapies.
- Identifying patients at risk for relapse or resistance is crucial for optimizing treatment strategies.
- Awareness of complications from prolonged immunosuppression is essential for comprehensive patient care and improved long-term outcomes in MCNS management.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Acute Kidney Injury V: Interprofessional Care
Diabetic Nephropathy
Kidney Transplant III: Nursing Management
Nephrons
